文献速递皮肤肿瘤

1990至2019年美国黑色素瘤与非黑色素瘤皮肤癌疾病负担

United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019.
PubMed 文献 · J Am Acad Dermatol · 2021-04-20

基于全球疾病负担2019数据,评估1990至2019年美国皮肤癌年龄标化发病率、患病率、伤残调整生命年(DALY)和死亡率。2019年黑色素瘤每10万人发病率17.0、患病率138、DALY 64.8、死亡率2.2;鳞状细胞癌分别为262、314、26.6、0.8;基底细胞癌分别为525、51.2、0.2、0。黑色素瘤和非黑色素瘤皮肤癌的发病率和患病率自1990年以来上升,死亡率基本稳定;男性各项指标每年均高于女性;黑色素瘤发病和患病在美国北半部相对高于南半部。

要点

  • 2019年美国黑色素瘤每10万人发病率17.0、患病率138、DALY 64.8、死亡率2.2。
  • 鳞状细胞癌每10万人发病率262、患病率314、DALY 26.6、死亡率0.8。
  • 基底细胞癌每10万人发病率525、患病率51.2、DALY 0.2、死亡率为0。

核心结论

  • 1990至2019年美国黑色素瘤和非黑色素瘤皮肤癌的发病率和患病率上升,死亡率基本稳定。

研究设计与样本

  • 基于全球疾病负担2019数据,评估美国皮肤癌年龄标化发病率、患病率、DALY和死亡率。

主要发现

  • 2019年黑色素瘤每10万人发病率17.0、患病率138、DALY 64.8、死亡率2.2。
  • 2019年鳞状细胞癌每10万人发病率262、患病率314、DALY 26.6、死亡率0.8。
  • 2019年基底细胞癌每10万人发病率525、患病率51.2、DALY 0.2、死亡率为0。
  • 自1990年以来,男性黑色素瘤和非黑色素瘤皮肤癌的发病率、患病率、DALY和死亡率每年均高于女性。
  • 黑色素瘤发病和患病在美国北半部相对高于南半部。

临床怎么用

  • 医疗专业人员可利用本研究的差异和趋势指导资源分配,以降低皮肤癌的发病率和疾病负担。

局限性

  • 全球疾病负担数据来源于估计和数学建模。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Skin cancer is the most common cancer worldwide. OBJECTIVE: To evaluate the burden of skin cancer in the US from 1990 to 2019. METHODS: Age-standardized incidence, prevalence, disability-adjusted life years (DALY), and mortality rates from skin cancer in the US were evaluated from the Global Burden of Disease 2019. RESULTS: Incidence, prevalence, DALY, and mortality rates for melanoma per 100,000 persons in 2019 were 17.0, 138, 64.8, and 2.2, respectively; for squamous cell carcinoma, rates were 262, 314, 26.6, and 0.8, respectively; and for basal cell carcinoma, rates were 525, 51.2, 0.2, and zero, respectively. Incidence and prevalence rates of melanoma and non-melanoma skin cancer (NMSC) have increased since 1990, while mortality rates have remained fairly stable. Males have had higher incidence, prevalence, DALY, and mortality rates from melanoma and NMSC every year since 1990. Incidence and prevalence of melanoma was relatively higher in the northern half of the US than in the southern half. LIMITATIONS: Global Burden of Disease is derived from estimation and mathematical modeling. CONCLUSIONS: Health care professionals can utilize differences and trends noted in this study to guide allocation of resources to reduce incidence and morbidity from skin cancer.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Aggarwal P, Knabel P, Fleischer AB, et al. United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019. J Am Acad Dermatol. 2021. PMID: 33852922. doi:10.1016/j.jaad.2021.03.109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。